An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma: implications for adjuvant treatment.
Atıf İçin Kopyala
Fisher S., Patel S., Bagci P., Kooby D., El-Rayes B., Staley C., ...Daha Fazla
Cancer, cilt.119, ss.445-53, 2013 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
119
-
Basım Tarihi:
2013
-
Doi Numarası:
10.1002/cncr.27619
-
Dergi Adı:
Cancer
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.445-53
-
Anahtar Kelimeler:
excision cross-complementing gene-1, ribonucleotide reductase subunit 1, ribonucleotide reductase subunit 2, human equilibrative nucleoside transporter-1, pancreas cancer, biomarkers, 3-AMINOPYRIDINE-2-CARBOXALDEHYDE THIOSEMICARBAZONE 3-AP, CELL LUNG-CANCER, ADJUVANT CHEMOTHERAPY, PREDICTS SURVIVAL, GEMCITABINE, TRIAL, PHARMACOGENETICS, CHEMOSENSITIVITY, CYTOTOXICITY, INHIBITION
-
Marmara Üniversitesi Adresli:
Hayır